Health16h agoAsianet Newsable

Takeda's dengue vaccine QDENGA gets DCGI approval for use in India

in5points

Takeda's dengue vaccine QDENGA has received DCGI approval for use in India.
QDENGA is the first dengue vaccine approved in India, authorised for individuals aged 4-60.
Market authorisation was granted without requiring pre-vaccination testing.
The approval marks a significant step in India's dengue prevention efforts.

Story angle

Center-right

Mostly straight facts, with a light government- or market-friendly tilt.

About how the story is framed, not whether the facts are true.

Center-right

Mixed factuality

Who owns this?

Asianet News Network

Rajeev Chandrasekhar / Jupiter Capital interests historically

UPSC / SSC structured brief for this story — not the five-point card.

Left blind spot

Only right-leaning outlets are covering this so far.

Outlet lean

2 sources

Left

Center

Right

Compare headlines

Same story, different framing

CenterTimes of India
India approves its first dengue vaccine QDENGA after DCGI clearance
The Times of India presents the approval as a straightforward public health milestone, with neutral factual reporting.
RightAsianet Newsable
Takeda's dengue vaccine QDENGA gets DCGI approval for use in India
The outlet frames this as a positive milestone for dengue prevention in India, highlighting the approval of a new vaccine without pre-testing requirements.

›

2 outlets